ASHLEY NEAL: Open Payments
NPI 1386232544 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,480 in 203 payments from 22 companies in 2025. Trend: 2023 $909 · 2024 $5,449 · 2025 $4,480
Food & beverage: $4,269Education: $211
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $641 |
| ABBVIE INC. | 32 | $629 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $509 |
| Vanda Pharmaceuticals Inc. | 18 | $438 |
| E.R. Squibb & Sons, L.L.C. | 13 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $249 |
| Indivior Inc. | 10 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $220 |
| Alkermes, Inc. | 8 | $208 |
| Lundbeck LLC | 11 | $198 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, COBENFY, TRINTELLIX, UZEDY, SUBLOCADE.
Industry payments across CT — which companies pay providers there.
